Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 5, 2013, Pages 609-617

  Cao, W H ^a   Liu, H M ^a   Liu, X ^a   Li, J G ^a   Liang, J ^a   Liu, M ^a   Niu, Z H ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Breast cancer; Invasion; MMPs; Relaxin; S100A4

Indexed keywords

CALVASCULIN; GELATINASE A; GELATINASE B; RELAXIN; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL INVASION; CONTROLLED STUDY; ENZYME INDUCTION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME INDUCTION; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; RELAXIN; S100 PROTEINS; SIGNAL TRANSDUCTION; SWINE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84878529556     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. DAVIES BR, DAVIES MP, GIBBS FE, BARRACLOUGH R, RUDLAND PS. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calciumbinding protein, but not with the oncogene EJ-ras-1. Oncogene 1993, 8: 999-1008.
2. OATES AJ, BARRACLOUGH R, RUDLAND PS. The identification of metastasis-related gene products in a rodent mammary tumour model. Biochem Soc Trans 1996; 24: 353S.
3. MAZOUJIAN G, BRYANT-GREENWOOD GD. Relaxin in breast tissue. Lancet 1990; 335(8684): 298-299.
4. SACCHI TB, BANI D, BRANDI ML, FALCHETTI A, BIGAZZI M. Relaxin influences growth, differentiation and cell-cell adhesion of human breast-cancer cells in culture. Int J Cancer 1994; 57: 129-134.
5. BANI D, FLAGIELLO D, POUPON MF, NISTRI S, POIRSONBICHAT F, BIGAZZI M, BANI SACCHI T. Relaxin promotes differentiation of human breast cancer cells MCF-7 transplanted into nude mice. Virchows Arch 1999; 435: 509-519.
6. BINDER C, HAGEMANN T, HUSEN B, SCHULZ M, EINSPANIER A. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Mol Hum Reprod 2002; 8: 789-796.
7. SILVERTOWN JD, GEDDES BJ, SUMMERLEE AJ. Adenovirusmediated expression of human prorelaxin promotes the invasive potential of canine mammary cancer cells. Endocrinology 2003; 144: 3683-3691.
8. KAMAT AA, FENG S, AGOULNIK IU, KHERADMAND F, BOGATCHEVA NV, COFFEY D, SOOD AK, AGOULNIK AI. The role of relaxin in endometrial cancer. Cancer Biol Ther 2006; 5: 71-77.
9. HOMBACH-KLONISCH S, BIALEK J, Trojanowicz B. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells. Am J Pathol 2006; 169: 617-632.
10. BOYE K, MAELANDSMO GM. S100A4 and metastasis: a small actor playing many roles. Am J Pathol. 2010; 176: 528-535.
11. JENKINSON SR, BARRACLOUGH R, WEST CR, RUDLAND PS. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. Br J Cancer 2004; 90: 253-262.
12. ISMAIL NI, KAUR G, HASHIM H, HASSAN MS. S100A4 overexpression proves to be independent marker for breast cancer progression. Cancer Cell Int 2008; 8: 12.
13. SCHMIDT-HANSEN B, ORNAS D, GRIGORIAN M. Extracellular S100A4 (mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004; 23: 5487-5495.
14. ZHANG G, LI M, JIN J, BAI Y, YANG C. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9. Asian Pac J Cancer Prev 2011; 12: 2075-2080.
15. SALEEM M, KWEON MH, JOHNSON JJ, ADHAMI VM, ELCHEVA I, KHAN N, BIN HAFEEZ B, BHAT KM, SARFARAZ S, REAGAN-SHAW S, SPIEGELMAN VS, SETALURI V, MUKHTAR H. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci U S A 2006; 103: 14825-14830.
16. WANG L, WANG X, LIANG Y, DIAO X, CHEN Q. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13. Acta Biochim Pol 2012 Nov 16.
17. RADESTOCK Y, WILLING C, KEHLEN A, HOANG-VU C, HOMBACH-KLONISCH S. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts. Mol Cancer Res 2010; 8: 494-506.
18. RADESTOCK Y, HOANG-VU C, HOMBACH-KLONISCH S. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells. Breast Cancer Res 2008; 10: R71.
19. SOOD AK, COFFIN JE, SCHNEIDER GB, FLETCHER MS, DEYOUNG BR, GRUMAN LM, GERSHENSON DM, SCHALLER MD, HENDRIX MJ. Biological significance of focal adhesion kinase in ovarian cancer: Role in migration and invasion. Am J Pathol 2004; 165: 1087-1095.
20. SOBRIN L, LIU Z, MONROY DC, SOLOMON A, SELZER MG, LOKESHWAR BL, PLUGFELDER SC. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci 2000; 41: 1703-1709.
21. WYATT TA, SISSON JH, FORGET MA, BENNETT RG, HAMEL FG, SPURZEM JR. Relaxin stimulates bronchial epithelial cell PKA activation, migration, and ciliary beating. Exp Biol Med 2002; 227: 1047-1053.
22. FIGUEIREDO KA, PALMER JB, MUI AL, NELSON CC, COX ME. Demonstration of upregulated H2 relaxin Mrna expression during neuroendocrine differentiation of LNCaP prostate cancer cells and production of biologically active mammalian recombinant 6 histidine-tagged H2 relaxin. Ann NY Acad Sci 2005; 23: 804-811.
23. THOMPSON VC, MORRIS TG, COCHRANE DR, CAVANAGH J, WAFA LA, HAMILTON T, WANG S, FAZLI L, GLEAVE ME, NELSON CC. Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens. Prostate 2006; 66: 1698-1709.
24. SILVERTOWN JD, GEDDES BJ, SUMMERLEE AJ. Adenovirus- mediated expression of human prorelaxin promotes the invasive potential of canine mammary cancer cells. Endocrinology 2003; 144: 3683-3691.
25. UNEMORI EN, AMENTO EP. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 1990; 265: 10681-10685.
26. PALEJWALA S, TSENG L, WOJTCZUK A, WEISS G, GOLDSMITH LT. Relaxin gene and protein expression and its regulation of procollagenase and vascular endothelial growth factor in human endometrial cells. Biol Reprod 2002; 66: 1743-1748.
27. UNEMORI EN, LEWIS M, GROVE BH, DESHPANDE U. Relaxin induces specific alterations in gene expression in human endometrial stromal cells. In: Tregear G, Ivell R, Bathgate R, Wade JD, eds. Proceedings from the Third International Congress on Relaxin and Related Peptides. Dordrecht: Kluwer Academic Publisher, 2002; pp. 65-72.
28. SHERBET GV. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 2009; 280: 15-30.
29. ZHANG K, ZHANG M, ZHAO H, YAN B, ZHANG D, LIANG J. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway. Dis Esophagus 2012; 25: 731-739.
30. CHEN D, ZHENG XF, YANG ZY, LIU DX, ZHANG GY, JIAO XL, ZHAO H. S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.World J Gastroenterol 2012; 18: 915-922.
31. HOMBACH-KLONISCH S, BIALEK J, TROJANOWICZ B. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells. Am J Pathol 2006; 169: 617-632.
32. LI J, LI F, WANG H, WANG X, JIANG Y, LI D.Wortmannin reduces metastasis and angiogenesis of human breast cancer cells via nuclear factor-êB- dependent matrix metalloproteinase-9 and interleukin-8 pathways. J Int Med Res 2012; 40: 867-876.
33. KE Z, LIN H, FAN Z, CAI TQ, KAPLAN RA, MA C, BOWER KA, SHI X, LUO J. MMP-2 mediates ethanol-induced invasion of mammary epithelial cells overexpressing ErbB2. Int J Cancer 2006; 119: 8-16.
34. RADESTOCK Y, HOANG-VU C, HOMBACH-KLONISCH S. Relaxin downregulates the calcium binding protein S100A4 in MDA-MB-231 human breast cancer cells. Ann N Y Acad Sci 2005; 1041: 462-469.
35. DELASSUS GS, CHO H, PARK J, ELICEIRI GL. New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells. J Cell Physiol 2008; 217: 739-744.